The combined organization will offer a comprehensive suite of AI-enabled medical imaging solutions across X-ray and DXA modalities, ranging from automated fracture detection and opportunistic bone fragility assessment to fracture risk prediction. Medimaps Group’s bone microarchitecture solutions – including TBS Osteo and TBS Reveal – together with RBfracture, Radiobotics’ flagship solution for detecting trauma-related findings, integrate seamlessly into existing radiology workflows through PACS-enabled capabilities.

The mission of the combined entity will be to solve the silent crisis of bone health by closing the gap between reactive diagnostics and preventative care. This partnership will create the world’s first end-to-end MSK AI ecosystem, where every X-ray becomes a tool for both detection and long-term risk prediction. To achieve this at scale, the organization will leverage its combined clinical expertise, operational capabilities, and established distribution networks to expand access to its portfolio across 90 markets worldwide – including the United States – serving hospitals, clinics, and imaging centers.